RMSL News:
REMSleep in Final Stages of Introducing the New Deltawave to Market
9:53 AM ET 11/4/19 | GlobeNewswire
REMSleep in Final Stages of Introducing the New Deltawave to Market
Orlando, FL, Nov. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- REMSleep Holdings, Inc. (OTC PINK: RMSL) has production inventory on hand of the new Deltawave CPAP interface mask. The company has also just received completed packaging for product. However, some additional environmental regulatory testing is required which will delay market introduction a little longer. The company has completed negotiations for the company's branded CPAP machine and we are proceeding to filing for 510 K clearance to introduce the company's new CPAP machine to market.
The company had to change to a new internet design company, which has caused an additional delay for our new commerce web site. All delays were unexpected, but the delays are necessary. Along with delays the company has made great strides. REMSleep will do well in the short run and progress into a substantial company. We greatly appreciate all those who have confidence in management and remain steadfast with REMSleep. REMSleep will schedule a conference call in the near future for a complete informative formal update.
REMSleep Holdings, Inc. was founded to design and manufacture devices and products for the treatment of sleep apnea and other respiratory conditions. With over 50 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. REMSleep Holdings, Inc. has a new patent pending, innovative sleep apnea product that will meet multiple market needs and then be able to reach and address a large percentage of the patient population who continue to struggle with CPAP compliance.
